Geode Capital Management
JBIO

Geode Capital Management’s Jade Biosciences JBIO Stock Holding History

Geode Capital Management’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.9M Buy
985,178
+162,658
+20% +$3.39M ﹤0.01% 2102
2026
Q1 		$11.6M Sell
822,520
-19,288
-2% -$279K ﹤0.01% 2300
2025
Q4 		$13M Buy
841,808
+175,893
+26% +$2.06M ﹤0.01% 2269
2025
Q3 		$5.75M Sell
665,915
-10,516
-2% -$85.9K ﹤0.01% 2710
2025
Q2 		$6.76M Buy
676,431
+668,000
+7,923% +$22.7M ﹤0.01% 2577
2025
Q1 		$741K Buy
8,431
+12
+0.1% +$1.05K ﹤0.01% 3407
2024
Q4 		$781K Buy
8,419
+79
+0.9% +$6.81K ﹤0.01% 3450
2024
Q3 		$610K Sell
8,340
-722
-8% -$46.6K ﹤0.01% 3531
2024
Q2 		$527K Buy
9,062
+1,012
+13% +$671K ﹤0.01% 3555
2024
Q1 		$8.33M Buy
8,050
+139
+2% +$106K ﹤0.01% 2434
2023
Q4 		$6.27M Buy
7,911
+774
+11% +$394K ﹤0.01% 2588
2023
Q3 		$3.39M Buy
7,137
+1,335
+23% +$723K ﹤0.01% 2838
2023
Q2 		$3.48M Buy
5,802
+445
+8% +$285K ﹤0.01% 2885
2023
Q1 		$3.78M Buy
5,357
+254
+5% +$211K ﹤0.01% 2757
2022
Q4 		$5.23M Buy
5,103
+257
+5% +$187K ﹤0.01% 2640
2022
Q3 		$2.81M Buy
4,846
+99
+2% +$66.1K ﹤0.01% 2963
2022
Q2 		$2.6M Sell
4,747
-830
-15% -$396K ﹤0.01% 3021
2022
Q1 		$3.58M Buy
5,577
+1,070
+24% +$415K ﹤0.01% 2970
2021
Q4 		$1.86M Buy
4,507
+1,238
+38% +$626K ﹤0.01% 3398
2021
Q3 		$2.4M Buy
+3,269
New +$1.83M ﹤0.01% 3269

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management's JBIO Position: Q2 2026 in Review

Geode Capital Management increased its Jade Biosciences (JBIO) stake by 20% in Q2 2026, buying an estimated $3.39M and bringing the position to 985,178 shares worth $21.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2102.

Geode Capital Management first reported a position in JBIO in Q3 2021 and has held it in 20 quarters since. 154 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • Geode Capital Management held 985,178 shares of Jade Biosciences worth $21.9M as of Q2 2026.
  • Geode Capital Management bought 162,658 Jade Biosciences shares in Q2 2026, an estimated $3.39M.
  • Jade Biosciences made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2102 holding.
  • Geode Capital Management first reported a position in Jade Biosciences in Q3 2021 and has held it in 20 quarters since.
  • 154 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.